Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
Type
Retraction
Notice date
3/25/2021 0:00
Journal
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research